Global Biotech Corp. (Global or GBIQ) (OTCBB: GBIQ) (CNSX: GBQ), a public company formed under the laws and regulations of the State of Delaware in 2000, and headquartered in Toronto, Ontario, Canada. Global Biotech Corp. is dedicated to investigating and developing Green Technologies and natural health solutions, from ensuring potable water.

Global will achieve its goals initially through its health enriched line of beverages. Global is working to establish its Quantum Boost (QB) line of enhanced beverages as a leader in the specialty drinks market. QB1 oxygenated water, its initial product (previously known as AquaBoost) is being positioned to become one of the front runners in its area. The oxygenation level of QB1, along with its ability to retain this level of oxygenation, will give Global the ability to become a recognizedproducer in this specialty waters niche.

Global is currently in the process of developing, with pharmaceutical companies, natural oxygenated beverages and fruit juices. In fact, Global could gain tremendous market share by developing natural products for the nutraceutical, pharmaceutical and cosmeceutical industries. Global and its QB line of drink products could become staples in the specialty drink niche. The name AquaBoost will now be used to describe the oxygenation process of the technology and the QB product line will be branded as AquaBoost Inside.

The QB product line mission is to help combat the growing obesity in North America by profitably formulating and marketing great tasting, weight management beverages that provide healthy alternatives to other beverages. GBIQ short term objective is to successfully launch its QB product line into selected markets while continuing to build a corporate infrastructure to facilitate plans for future growth and anticipated rollouts of new products. Its long?term objective for QB is t o become a significant participant within the functional beverage sector, capturing a market share which would generate attention from the larger beverage industry giants. By doing so, GBIQ will be well positioned as an attractive acquisition candidate which any number of larger beverage companies might seek a partnership or joint venture.

The QB line of products, utilizing the marketing phrase bottled perfection will become a formidable competitor within the beverage industry, as per the Company? expectations. As it executes its business plan, GBIQ has the flexibility to emulate other small beverage companies that have come before them and have developed innovative products within the functional beverage marketplace. Several of these companies have continued on as independents and found their own success, while others have been acquired by one of the larger beverage brands like Coke, Pepsi, or Nestle.

Global is on the verge of developing a technology that will help replenish our potable water resource through its tribo-electric reactors. We have conclusive third party data that makes this endeavor is plausible. This will ensure the continuation of future generations of such a vital resource “Water”..

Global Biotech Corp. is dedicated to investigate and develop Green Technology platforms which apply environment science to conserve the natural science and resources, by curbing the negative impacts of human involvement.

Global Biotech Corp dedicated to providing potable water and medicinal beverages to the public.

The one of the business objectives of GLOBAL is to position the technology of  AquaBoost(TM) as a top quality oxygenated water in the specialty waters market because of its uniqueness. Our oxygenation level (up to 100 ppm and greater), the ability of our bottled water to retain this level of oxygenation, even over lengthy periods of time and the purity of our product, we believe, should give us the ability to become a recognized producer in this specialty waters niche. The Company is in the process of developing with Pharmaceutical companies natural oxygenated beverages and fruit juices.

OXYGENATED WATER, THE PRODUCT

Oxygen enriched water is water that is treated, combined or infused with oxygen. Most oxygen enriched water companies claim that their water contains around seven times the oxygen of natural, mineral, tap or spring water. For many of the available brands the oxygen content is acknowledged to decrease over time (giving products a shorter shelf life) and also decreases when the oxygen enriched water bottle is opened, as the oxygen slowly dissipates. Oxygenated water is a convenient source of additional oxygen for the body. The benefits of additional oxygen, according to the studies run and research done, include increased cardiovascular and muscular endurance. Oxygenated water raises the body’s energy levels, improves concentration, calms the nervous system, and helps to remove toxins.

PRODUCTION PROCESS

We have added new dimensions to the laws of physics governing dissolved gases. Our method of dissolving gases in a liquid works by influencing ionic mobility, electron diffusion, via an electron cannon, and the use of triboelectricity with electrostatic charges. Due to the aforementioned processes, we can attach and stabilize oxygen molecules in water at levels previously unheard of, 100PPM and even higher. Therefore, in contrast to a mineralized solution reducing the dissolvability of oxygen in water as would be the case with our competitors’ products, a small quantity of minerals helps us create conductivity in water. In effect, the amount of conductivity is influenced by the electrolyte strength, the nature of free ions and their concentration in water. The process modifies water’s physical and chemical characteristics and allows us to bond the oxygen molecule to water.

Global uses natural spring water in all its natural beverages and oxygenated drinks.

Medical benefits, of elevated oxygen levels, include:

Treatment of:                                               Improvements in:

Infectious Diseases                                   Cognitive performance
Chronic wounds                                         Lowering blood pressure
Anemia/blood loss                                   Post operative wound care
Spinal cord injury                                      Depression
Cerebral Damage                                        Sleep Disorders
Burn Victims                                                Chronic joint and muscular pain
Chronic Fatigue
Respiratory and Heart problems
Stimulation of metabolism

About Medical Care Technologies Inc.

Medical Care Technologies Inc. is traded under the symbol MDCE on the OTCBB and is headquartered in Beijing, China.  MDCE, through joint ventures or Chinese subsidiaries, develops a network of children’s health facilities in the larger urban areas throughout China. Services are geared towards the advancing economic middle-class and upper class Chinese families. Specializing in the care of children between the ages of 3 to 16, MDCE’s role is to enhance the overall well-being of the family and community and to expand its pediatric services to include preventative health and wellness education. MDCE, through its children’s health facilities, will also distribute a diverse range of industry-leading pharmaceutical and nutraceutical product lines. MDCE’s main mission is simple – to become a healthcare service provider leader in children’s health. Information on the Company can be found at  <http://www.sec.gov/> www.sec.gov and the Company’s website at  <http://www.medicaretechinc.com/> www.medicaretechinc.com.

In January 2010, we signed an Asset Acquisition Agreement (“Asset Agreement”) with Great Union Corporation (“Great Union”). In consideration of the issuance of 57, 300,000 shares of our common stock, we acquired Great Union’s technologies associated with the development and maintenance of secure information systems which increase access to medical resources services, education and wellness, pharmaceutical and nutraceutical products.

Our main mission now is to open and operate private children’s health & wellness clinics throughout China. Concurrent with, and in addition to the clinics we operate, it is our plan to add to our bottom revenue line by offering affordable, standardized and secure software information systems to electronically connect healthcare providers, academic institutions, pharmaceutical and nutraceutical companies, alternative health companies and individual consumers with healthcare information, products and services in China.  We aim to generate e-management revenues and nutraceutical and pharmaceutical product distribution revenues.

Our planned products and/services also constitute a healthcare delivery and wellness site; dedicated to helping Chinese consumers live healthier, more balanced lives.  Further information on the Company’s filings can be found at www.sec.gov.

Medical Care Technologies Inc.’s common stock is traded on the OTC Bulletin Board Markets under the symbol “MDCE”.